150 related articles for article (PubMed ID: 27410178)
1. Jansen Metaphyseal Chondrodysplasia due to Heterozygous H223R-PTH1R Mutations With or Without Overt Hypercalcemia.
Nampoothiri S; Fernández-Rebollo E; Yesodharan D; Gardella TJ; Rush ET; Langman CB; Jüppner H
J Clin Endocrinol Metab; 2016 Nov; 101(11):4283-4289. PubMed ID: 27410178
[TBL] [Abstract][Full Text] [Related]
2. A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia.
Schipani E; Langman C; Hunzelman J; Le Merrer M; Loke KY; Dillon MJ; Silve C; Jüppner H
J Clin Endocrinol Metab; 1999 Sep; 84(9):3052-7. PubMed ID: 10487664
[TBL] [Abstract][Full Text] [Related]
3. A form of Jansen's metaphyseal chondrodysplasia with limited metabolic and skeletal abnormalities is caused by a novel activating parathyroid hormone (PTH)/PTH-related peptide receptor mutation.
Bastepe M; Raas-Rothschild A; Silver J; Weissman I; Wientroub S; Jüppner H; Gillis D
J Clin Endocrinol Metab; 2004 Jul; 89(7):3595-600. PubMed ID: 15240651
[TBL] [Abstract][Full Text] [Related]
4. Rare Variant of PTH1R Mutation in an Indian Family.
Parameswaran AS; Singh K; Vyas V; Tada NK
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116011
[TBL] [Abstract][Full Text] [Related]
5. Substantially Delayed Maturation of Growth Plate Chondrocytes in "Humanized"
Reyes M; Firat D; Hanna P; Khan M; Bruce M; Shvedova M; Kobayashi T; Schipani E; Gardella TJ; Jüppner H
JBMR Plus; 2023 Oct; 7(10):e10802. PubMed ID: 37808400
[TBL] [Abstract][Full Text] [Related]
6. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia.
Schipani E; Langman CB; Parfitt AM; Jensen GS; Kikuchi S; Kooh SW; Cole WG; Jüppner H
N Engl J Med; 1996 Sep; 335(10):708-14. PubMed ID: 8703170
[TBL] [Abstract][Full Text] [Related]
7. Potential effects of alendronate on fibroblast growth factor 23 levels and effective control of hypercalciuria in an adult with Jansen's metaphyseal chondrodysplasia.
Onuchic L; Ferraz-de-Souza B; Mendonca BB; Correa PH; Martin RM
J Clin Endocrinol Metab; 2012 Apr; 97(4):1098-103. PubMed ID: 22278430
[TBL] [Abstract][Full Text] [Related]
8. Progression of Mineral Ion Abnormalities in Patients With Jansen Metaphyseal Chondrodysplasia.
Saito H; Noda H; Gatault P; Bockenhauer D; Loke KY; Hiort O; Silve C; Sharwood E; Martin RM; Dillon MJ; Gillis D; Harris M; Rao SD; Pauli RM; Gardella TJ; Jüppner H
J Clin Endocrinol Metab; 2018 Jul; 103(7):2660-2669. PubMed ID: 29788189
[TBL] [Abstract][Full Text] [Related]
9. An Inverse Agonist Ligand of the PTH Receptor Partially Rescues Skeletal Defects in a Mouse Model of Jansen's Metaphyseal Chondrodysplasia.
Noda H; Guo J; Khatri A; Dean T; Reyes M; Armanini M; Brooks DJ; Martins JS; Schipani E; Bouxsein ML; Demay MB; Potts JT; Jüppner H; Gardella TJ
J Bone Miner Res; 2020 Mar; 35(3):540-549. PubMed ID: 31693237
[TBL] [Abstract][Full Text] [Related]
10. The PTH/PTHrP receptor in Jansen's metaphyseal chondrodysplasia.
Calvi LM; Schipani E
J Endocrinol Invest; 2000 Sep; 23(8):545-54. PubMed ID: 11021773
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a PTH1R missense mutation responsible for Jansen type metaphyseal chondrodysplasia.
Shimomura-Kuroki J; Farooq M; Sekimoto T; Amizuka N; Shimomura Y
Odontology; 2017 Apr; 105(2):150-154. PubMed ID: 27160269
[TBL] [Abstract][Full Text] [Related]
12. Jansen-type metaphyseal chondrodysplasia: analysis of PTH/PTH-related protein receptor messenger RNA by the reverse transcriptase-polymerase chain method.
Minagawa M; Arakawa K; Takeuchi S; Minamitani K; Yasuda T; Niimi H
Endocr J; 1997 Aug; 44(4):493-9. PubMed ID: 9447281
[TBL] [Abstract][Full Text] [Related]
13. Severe hypertension-An infantile feature of Jansen metaphyseal chondrodysplasia?
Gabbett MT; Jeavons CJ; Gray PH
Am J Med Genet A; 2020 Apr; 182(4):768-772. PubMed ID: 31977144
[TBL] [Abstract][Full Text] [Related]
14. Constitutive activation of the cyclic adenosine 3',5'-monophosphate signaling pathway by parathyroid hormone (PTH)/PTH-related peptide receptors mutated at the two loci for Jansen's metaphyseal chondrodysplasia.
Schipani E; Jensen GS; Pincus J; Nissenson RA; Gardella TJ; Jüppner H
Mol Endocrinol; 1997 Jun; 11(7):851-8. PubMed ID: 9178745
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel heterozygous PTH1R variant in a Chinese family with incomplete penetrance.
Wang J; Zhao C; Zhang X; Yang L; Hu Y
Mol Genet Genomic Med; 2024 Jan; 12(1):e2301. PubMed ID: 37840415
[TBL] [Abstract][Full Text] [Related]
16. Jansen's metaphyseal chondrodysplasia: a disorder due to a PTH/PTHrP receptor gene mutation.
Jüppner H
Trends Endocrinol Metab; 1996 Jul; 7(5):157-62. PubMed ID: 18406742
[TBL] [Abstract][Full Text] [Related]
17. Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia.
Brown WW; Jüppner H; Langman CB; Price H; Farrow EG; White KE; McCormick KL
J Clin Endocrinol Metab; 2009 Jan; 94(1):17-20. PubMed ID: 18854401
[TBL] [Abstract][Full Text] [Related]
18. Prenatal presentation and postnatal evolution of a patient with Jansen metaphyseal dysplasia with a novel missense mutation in PTH1R.
Savoldi G; Izzi C; Signorelli M; Bondioni MP; Romani C; Lanzi G; Moratto D; Verdoni L; Pinotti M; Prefumo F; Superti-Furga A; Pilotta A
Am J Med Genet A; 2013 Oct; 161A(10):2614-9. PubMed ID: 23950054
[TBL] [Abstract][Full Text] [Related]
19. The cyclin D1 and cyclin A genes are targets of activated PTH/PTHrP receptors in Jansen's metaphyseal chondrodysplasia.
Beier F; LuValle P
Mol Endocrinol; 2002 Sep; 16(9):2163-73. PubMed ID: 12198252
[TBL] [Abstract][Full Text] [Related]
20. Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.
Jobert AS; Zhang P; Couvineau A; Bonaventure J; Roume J; Le Merrer M; Silve C
J Clin Invest; 1998 Jul; 102(1):34-40. PubMed ID: 9649554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
